Ischemia-reperfusion Injury Clinical Trial
Official title:
Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery: a Randomised Controlled Study
Background. Cardiopulmonary bypass in on-pump cardiac surgery (OPCS) can have harmful effects
by ischemia-reperfusion. No data about the effects of remote ischemic postconditioning (RIP)
in hypoxia-inducible factor-1 alpha (HIF-1α) plasma level after OPCS. The aim of this study
is evaluate the effects of RIP on postoperative HIF-1α plasma levels, cardiac markers and
arterial oxygenation of patients after OPCS.
Methods. Randomised controlled study in 70 patients undergoing OPCS: 35 patients receive RIP
(RIP group) and 35 patients not (control group). Patients receive RIP on upper limb: 5 min of
ischemia followed by 5 min of reperfusion (3 cycles) immediately after leaving on-pump. The
primary outcome was to know the HIF-1α plasma levels after surgery in both groups: before
starting surgery (T0) and after CPB period at 2 h (T1), 8 h (T2), 24 h (T3), 36 h (T4), 48 h
(T5). Secondary outcomes included to measure the cardiac markers levels (Troponin T, CK-MB,
CPK), arterial oxygenation (PaO2/FiO2) and others.
Cardiac surgery with cardiopulmonary bypass (CPB) is associated with ischemia-reperfusion
(I-R) injury. Acute myocardial injury after cardiac surgery is associated with increased
mortality and morbidity. In 1993, reported that brief circumflex artery occlusion reduces
myocardial infarct size induced by a definitive occlusion of the left anterior descending
artery, a phenomenon which has been named remote ischemic preconditioning (RIPC). This
approach confers resistance to subsequent ischemic episodes in remote organs, possibly by
transferring protective mediators through humoral, neuronal, and systemic mechanisms, however
the mechanisms involved are not yet fully known. A recent study has found that
cardioprotection induced by RIPC the mitochondria appear to be an important subcellular
effector organelle. It has been reported that RIPC could be a potential protective approach
for perioperative complications. Therefore, the effects on myocardial injury and clinical
outcome in patients undergoing on-pump cardiac surgery (OPCS) are inconclusive. In the
present study, we conducted a randomized clinical trial on patients undergoing OPCS by
application of remote ischemic postconditioning (RIP), an alternative to remote ischemic
preconditioning. RIP can be applied in different clinical situations, medical or surgical,
when reperfusion is initiated and associated to acidosis, nitric oxide formation,
mitochondrial permeability transition pore inhibition and reactive oxygen species generation.
In the present study we have opted for remote postconditioning because we speculate a
possible losses of plasmatic effectors during CPB procedures using polyvinylchloride (PVC)
tubing. Since, when blood is exposed to the PVC surface the plasma proteins may be adsorbed.
Also to minimize the bleeding or hemodilution effects on the potential protective plasmatic
effectors levels during CPB.
Tissue exposure to low O2 concentration starts a hypoxic response of the hypoxia-inducible
factor 1 (HIF-1), a transcription factor heterodimer, consisting of an O2 regulated HIF-1α
subunit and a constitutively expressed HIF-1β subunit that binds to the consensus sequence
5'-RCGTG-3', which is present near HIF-1-regulated genes. HIF-1α protein stability is
upregulated in response to hypoxia. HIF-1α protein stability is negatively regulated by
O2-dependent prolyl hydroxylation and is degraded under normoxia by prolyl hydroxylase.
HIF-1α plays a critical role in the mammalian cells activating genes associate with
angiogenesis, ischemia, energy metabolism and cell cycle.
The aim of this study carried out in patients undergoing OPCS was the determination of the
time course of HIF-1α plasma levels in response to RIP and the possible correlation between
aortic cross-clamping time and HIF-1α plasma levels in both groups. HIF-1α role in remote
ischemic conditioning (pre or post) is very little known. Therefore, we tested the hypothesis
that RIP induces cardiac protection after OPCS and that this is associated to an increase of
HIF-1α plasma levels.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05327348 -
Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery
|
Phase 3 | |
Completed |
NCT00184912 -
The Effect of Caffeine on Ischemic Preconditioning
|
N/A | |
Recruiting |
NCT05585255 -
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
|
||
Completed |
NCT05598177 -
Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass
|
Phase 4 | |
Withdrawn |
NCT00441714 -
Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise
|
N/A | |
Completed |
NCT00248040 -
Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation
|
Phase 2 | |
Completed |
NCT01486212 -
Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers
|
N/A | |
Recruiting |
NCT06097702 -
A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants
|
Phase 1 | |
Completed |
NCT00224406 -
Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation
|
Phase 2 | |
Completed |
NCT01073202 -
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
|
N/A | |
Completed |
NCT05246618 -
FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT02118753 -
The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium
|
N/A | |
Completed |
NCT01739088 -
Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery
|
N/A | |
Completed |
NCT01040013 -
Gut Oxygenation and Laparoscopy
|
Phase 2 | |
Suspended |
NCT00184847 -
Adenosine Receptors Influence Ischemia-Reperfusion Injury
|
N/A | |
Completed |
NCT01172171 -
The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction
|
Phase 2 | |
Completed |
NCT00457405 -
Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
|
Phase 4 | |
Completed |
NCT00184821 -
Ischemic Injury and Ischemic Preconditioning in Diabetes
|
N/A | |
Not yet recruiting |
NCT00691613 -
Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model
|
N/A | |
Completed |
NCT03818126 -
The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement
|
N/A |